Supplementary Methods; Supplementary Figures 1 Through 9 from Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia

Zhiyong Liao,Lin Gu,Jenny Vergalli,Samanta A. Mariani,Marco De Dominici,Ravi K. Lokareddy,Ayush Dagvadorj,Puranik Purushottamachar,Peter A. McCue,Edouard J. Trabulsi,Costas D. Lallas,Shilpa Gupta,Elyse Ellsworth,Shauna Blackmon,Adam Ertel,Paolo Fortina,Benjamin E. Leiby,Guanjun Xia,Hallgeir Rui,David T. Hoang,Leonard G. Gomella,Gino Cingolani,Vincent C.O. Njar,Nagarajan Pattabiraman,Bruno Calabretta,Marja T. Nevalainen

DOI: https://doi.org/10.1158/1535-7163.22501902

2023-01-01

Abstract:Supplementary Methods. Supplementary Figure 1. Chemical structures of the small molecule IST5-002 analogs. Supplementary Figure 2. IST5-002 inhibits phosphorylation of Stat5 in mouse and human breast cancer cells. Supplementary Figure 3. IST5-002 does not have significant inhibitory activity against 50 kinases tested. Supplementary Figure 4. IST5-002 does not affect phosphorylation of Pak1/2. Supplementary Figure 5. IST5-002 inhibits expression of Stat5 target genes in PC cells and in CML cells. Supplementary Figure 6. IST5-002 is not generally cytotoxic as determined by lack of cell death induction in cancer cell lines established from other organs. Supplementary Figure 7. CWR22Rv1 PC cells were inoculated subcutaneously into the flanks of castrated athymic nude mice supplied with sustained-release 5alpha-dihydrotestosterone (DHT)-pellets (n=10/group, 1 tumor/mouse, 1.5 ??107 CWR22Rv1 cells per site, 1 DHT pellet/mouse). Supplementary Figure 8. IST5-0-02 induces apoptosis in CWR22Rv1 tumors grown in nude mice and in clinical PCs cultured ex vivo in organ explant cultures. Supplementary Figure 9. IST5-002 induces extensive apoptotic death of imatinib-sensitive and -resistant CML cells.